Edinburgh health tech firms raise millions from investors
Continuous glucose, the 5th vital sign, now available as part of Current Health. Learn more about our partnership with Dexcom.

“Edinburgh-based Current (formerly snap40) announced on Thursday it had secured $8m (£6.1m) in seed financing. The firm uses a predictive analytics software platform to identify, in real-time, those whose health is at risk of deteriorating.”

Get Started Today

Schedule a Virtual Demo

Related Posts